Sathe N, Shaikh S, Bhavsar M, Parte L, et al. Safety, immunogenicity and efficacy of Relcovax(R), a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus. Vaccine 2023 Oct 8:S0264-410X(23)01176-3. doi: 10.1016/j.vaccine.2023.
PMID: 37816655